vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and NATIONAL FUEL GAS CO (NFG). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $425.9M, roughly 2.2× NATIONAL FUEL GAS CO). NATIONAL FUEL GAS CO runs the higher net margin — 35.7% vs 0.7%, a 35.0% gap on every dollar of revenue. On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 1.7%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 12.1%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
National Fuel Gas Company is a diversified energy company with $6.2 billion in assets distributed among the following five operating segments: Exploration and Production, Pipeline and Storage, Gathering, Utility, and Energy Marketing. National Fuel Gas was incorporated in 1902 and is based in Williamsville, New York.
ASTH vs NFG — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $425.9M |
| Net Profit | $6.6M | $152.0M |
| Gross Margin | — | — |
| Operating Margin | 1.9% | 81.5% |
| Net Margin | 0.7% | 35.7% |
| Revenue YoY | 42.9% | 1.7% |
| Net Profit YoY | 184.4% | — |
| EPS (diluted) | $0.12 | $1.59 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $425.9M | ||
| Q4 25 | $950.5M | $637.9M | ||
| Q3 25 | $956.0M | $443.1M | ||
| Q2 25 | $654.8M | $527.4M | ||
| Q1 25 | $620.4M | $734.8M | ||
| Q4 24 | $665.2M | $513.8M | ||
| Q3 24 | $478.7M | $310.0M | ||
| Q2 24 | $486.3M | $338.6M |
| Q1 26 | — | $152.0M | ||
| Q4 25 | $6.6M | $181.6M | ||
| Q3 25 | $373.0K | $107.3M | ||
| Q2 25 | $9.4M | $149.8M | ||
| Q1 25 | $6.7M | $216.4M | ||
| Q4 24 | $-7.8M | $45.0M | ||
| Q3 24 | $16.1M | $-167.6M | ||
| Q2 24 | $19.2M | $-54.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 86.6% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 94.7% | ||
| Q1 25 | — | 81.6% | ||
| Q4 24 | — | 87.3% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 98.5% |
| Q1 26 | — | 81.5% | ||
| Q4 25 | 1.9% | 43.3% | ||
| Q3 25 | 2.0% | 40.6% | ||
| Q2 25 | 3.1% | 43.7% | ||
| Q1 25 | 3.3% | 43.2% | ||
| Q4 24 | 0.1% | 16.8% | ||
| Q3 24 | 5.9% | -63.4% | ||
| Q2 24 | 6.2% | -15.2% |
| Q1 26 | — | 35.7% | ||
| Q4 25 | 0.7% | 28.5% | ||
| Q3 25 | 0.0% | 24.2% | ||
| Q2 25 | 1.4% | 28.4% | ||
| Q1 25 | 1.1% | 29.4% | ||
| Q4 24 | -1.2% | 8.8% | ||
| Q3 24 | 3.4% | -54.1% | ||
| Q2 24 | 3.9% | -16.0% |
| Q1 26 | — | $1.59 | ||
| Q4 25 | $0.12 | $1.98 | ||
| Q3 25 | $0.01 | $1.18 | ||
| Q2 25 | $0.19 | $1.64 | ||
| Q1 25 | $0.14 | $2.37 | ||
| Q4 24 | $-0.14 | $0.49 | ||
| Q3 24 | $0.33 | $-1.81 | ||
| Q2 24 | $0.40 | $-0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | — |
| Total DebtLower is stronger | — | $300.0M |
| Stockholders' EquityBook value | $779.3M | — |
| Total Assets | $2.2B | $9.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $429.5M | $271.4M | ||
| Q3 25 | $463.4M | $43.2M | ||
| Q2 25 | $342.1M | $39.3M | ||
| Q1 25 | $260.9M | $40.0M | ||
| Q4 24 | $290.8M | $48.7M | ||
| Q3 24 | $350.3M | $38.2M | ||
| Q2 24 | $327.7M | $81.4M |
| Q1 26 | — | $300.0M | ||
| Q4 25 | — | $2.7B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $2.7B | ||
| Q1 25 | — | $2.7B | ||
| Q4 24 | — | $2.7B | ||
| Q3 24 | — | $2.7B | ||
| Q2 24 | — | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | $779.3M | $3.6B | ||
| Q3 25 | $775.5M | $3.1B | ||
| Q2 25 | $765.5M | $3.0B | ||
| Q1 25 | $745.4M | $2.8B | ||
| Q4 24 | $712.7M | $-76.2M | ||
| Q3 24 | $704.6M | $-15.5M | ||
| Q2 24 | $678.9M | $5.0M |
| Q1 26 | — | $9.1B | ||
| Q4 25 | $2.2B | $9.2B | ||
| Q3 25 | $2.2B | $8.7B | ||
| Q2 25 | $1.4B | $8.4B | ||
| Q1 25 | $1.3B | $8.5B | ||
| Q4 24 | $1.4B | $8.3B | ||
| Q3 24 | $1.3B | $8.3B | ||
| Q2 24 | $1.3B | $8.5B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.75× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 0.90× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 532.10× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $657.3M |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | 117.0% |
| Cash ConversionOCF / Net Profit | -0.44× | 4.32× |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $657.3M | ||
| Q4 25 | $-2.9M | $274.9M | ||
| Q3 25 | $10.0M | $237.8M | ||
| Q2 25 | $90.9M | $388.4M | ||
| Q1 25 | $16.6M | $253.8M | ||
| Q4 24 | $-10.9M | $220.1M | ||
| Q3 24 | $34.0M | $197.9M | ||
| Q2 24 | $23.2M | $281.8M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $-2.7M | ||
| Q3 25 | $7.4M | $-47.8M | ||
| Q2 25 | $89.5M | $195.3M | ||
| Q1 25 | $13.6M | $59.9M | ||
| Q4 24 | $-13.5M | $-20.3M | ||
| Q3 24 | $31.7M | $-49.1M | ||
| Q2 24 | $20.4M | $79.5M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | -0.4% | ||
| Q3 25 | 0.8% | -10.8% | ||
| Q2 25 | 13.7% | 37.0% | ||
| Q1 25 | 2.2% | 8.2% | ||
| Q4 24 | -2.0% | -4.0% | ||
| Q3 24 | 6.6% | -15.8% | ||
| Q2 24 | 4.2% | 23.5% |
| Q1 26 | — | 117.0% | ||
| Q4 25 | 0.3% | 43.5% | ||
| Q3 25 | 0.3% | 64.4% | ||
| Q2 25 | 0.2% | 36.6% | ||
| Q1 25 | 0.5% | 26.4% | ||
| Q4 24 | 0.4% | 46.8% | ||
| Q3 24 | 0.5% | 79.7% | ||
| Q2 24 | 0.6% | 59.7% |
| Q1 26 | — | 4.32× | ||
| Q4 25 | -0.44× | 1.51× | ||
| Q3 25 | 26.69× | 2.21× | ||
| Q2 25 | 9.65× | 2.59× | ||
| Q1 25 | 2.48× | 1.17× | ||
| Q4 24 | — | 4.89× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
NFG
| Revenues from External Customers | $425.8M | 100% |
| Intersegment Revenues | $126.0K | 0% |
